eisei's pcnsl [78 articles] Export

Recent papers added to eisei's library classified by the tag pcnsl. You can also see everyone's pcnsl.

	Protein Biomarker Identification in the CSF of Patients With CNS Lymphoma [My Copy] J Clin Oncol, Vol. 26, No. 1. (1 January 2008), pp. 96-105. by Sushmita Roy, Andrew S. Josephson, Jane Fridlyand, et al.Jon Karch, Cigall Kadoch, Juliana Karrim, Lloyd Damon, Patrick Treseler, Sandeep Kunwar, Marc A. Shuman, Ted Jones, Christopher H. Becker, Howard Schulman, James L. Rubenstein posted to pcnsl by eisei on 2009-01-15 03:10:07 as
	High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series [My Copy] J Clin Oncol, Vol. 16, No. 3. (1 March 1998), pp. 864-871. by J. Y. Blay, T. Conroy, C. Chevreau, et al.A. Thyss, N. Quesnel, H. Eghbali, R. Bouabdallah, B. Coiffier, J. P. Wagner, A. Le Mevel, D. Dramais-Marcel, E. Baumelou, F. Chauvin, P. Biron posted to pcnsl by eisei on 2009-01-15 03:08:59 as
	Calculated versus measured creatinine clearance for dosing methotrexate in the treatment of primary central nervous system lymphoma [My Copy] Cancer Chemotherapy and Pharmacology, Vol. 59, No. 6. (June 2007), pp. 817-823. by Gerber, David, Grossman, et al. Stuart, Batchelor, Tracy, Ye, Xiaobu posted to pcnsl by eisei on 2009-01-15 02:36:27 as
	LONG-TERM OUTCOME IN PCNSL PATIENTS TREATED WITH HIGH-DOSE METHOTREXATE AND DEFERRED RADIATION [My Copy] Neurology, Vol. 70, No. 5. (29 January 2008), pp. 401-402. by Elizabeth R. Gerstner, Kathryn A. Carson, Stuart A. Grossman, Tracy T. Batchelor posted to nabtt9607 pcnsl by eisei on 2009-01-15 02:35:31 as
	The development of targeted chemotherapy for CNS lymphoma-a pilot study of the IDARAM regimen. [My Copy] Cancer chemotherapy and pharmacology, Vol. 53, No. 4. (April 2004), pp. 324-328. by P. Moreton, G. J. Morgan, D. Gilson, et al.G. M. Smith, B. A. McVerry, J. M. Davies, M. J. Mackie, S. Bolam, S. S. Jalihal, M. R. Howard, L. A. Parapia, A. T. Williams, J. A. Child, posted to idarubicin pcnsl by eisei on 2009-01-14 14:36:22 as
	First-line therapy with temozolomide induces regression of primary CNS lymphoma [My Copy] Neurology, Vol. 58, No. 10. (28 May 2002), pp. 1573-1574. by U. Herrlinger, W. Kuker, M. Platten, J. Dichgans, M. Weller posted to hdmtx pcnsl by eisei on 2009-01-14 14:28:40 as
	Cognitive functions in survivors of primary central nervous system lymphoma [My Copy] Neurology, Vol. 62, No. 4. (24 February 2004), pp. 548-555. by D. D. Correa, L. M. Deangelis, W. Shi, H. Thaler, A. Glass, L. E. Abrey posted to pcnsl qol by eisei on 2009-01-14 10:01:32 as
	First-line autologous stem cell transplantation in primary CNS lymphoma [My Copy] European Journal of Haematology, Vol. 75, No. 4. (October 2005), pp. 288-292. by M. Brevet, R. Garidi, B. Gruson, B. Royer, I. Vaida, G. Damaj posted to pcnsl pcnsl-apbsct by eisei on 2009-01-14 08:42:49 as
	Cerebrospinal fluid diffusion of Zevalin after high-activity treatment and stem cell support in a patient affected by diffuse large B-cell non-Hodgkin's lymphoma with central nervous system involvement [My Copy] Annals of Oncology, Vol. 16, No. 10. (October 2005), pp. 1710-1711. by P. F. Ferrucci, A. Vanazzi, G. Tesoriere, et al.M. Ferrari, M. Bartolomei, P. Rocca, M. Cremonesi, G. Paganelli, G. Martinelli posted to pcnsl rituximab zavalin by eisei on 2009-01-14 06:15:55 as
	In Reply [My Copy] J Clin Oncol, Vol. 25, No. 28. (1 October 2007), pp. 4509-4511. by James Rubenstein, Lauren Abrey, Ranjana Advani, Marc Shuman, Tony Tsai, Joan O'Brien posted to intra-csf pcnsl rituximab by eisei on 2009-01-14 06:13:01 as
	Treatment of primary central nervous system lymphoma with induction of complement-dependent cytotoxicity by intraventricular administration of autologous-serum-supplemented rituximab [My Copy] Cancer Science, Vol. 97, No. 1. (2006), pp. 80-83. by Akiyoshi Takami, Tomoe Hayashi, Daisuke Kita, Ryosei Nishimura, Hidesaku Asakura, Shinji Nakao posted to pcnsl rituximab by eisei on 2009-01-14 05:00:06 as
	Primary central nervous system lymphoma in Japan: Changes in clinical features, treatment, and prognosis during 1985-2004 [My Copy] Neuro-oncol, Vol. 10, No. 4. (1 August 2008), pp. 560-568. by Yuta Shibamoto, Hiroyuki Ogino, Gen Suzuki, et al.Mitsuhiro Takemoto, Norio Araki, Koichi Isobe, Emiko Tsuchida, Katsumasa Nakamura, Masahiro Kenjo, Kazunori Suzuki, Masako Hosono, Sunao Tokumaru, Shun-Ichi Ishihara, Eriko Kato, Noriko Ii, Naofumi Hayabuchi posted to pcnsl by eisei on 2009-01-08 10:52:17 as
	Primary CNS lymphoma. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 24, No. 8. (10 March 2006), pp. 1281-1288. by T. Batchelor, J. S. Loeffler posted to pcnsl by eisei on 2009-01-08 10:43:50 as
	Primary CNS lymphoma: tumor-related clones exist in the blood and bone marrow with evidence for separate development. [My Copy] Blood (18 December 2008) by Katy J J. McCann, Margaret Ashton-Key, Kellyann Smith, Freda K K. Stevenson, Christian H H. Ottensmeier posted to pcnsl by eisei on 2009-01-08 10:37:59 as
	Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma. [My Copy] European journal of haematology, Vol. 70, No. 4. (April 2003), pp. 219-224. by E. Arellano-Rodrigo, A. López-Guillermo, E. M. Bessell, B. Nomdedeu, E. Montserrat, F. Graus posted to pcnsl by eisei on 2009-01-08 10:34:24 as
	Systemic high-dose methotrexate plus ifosfamide is highly effective for central nervous system (CNS) involvement of lymphoma. [My Copy] Annals of hematology, Vol. 88, No. 2. (February 2009), pp. 133-139. by L. Fischer, A. Korfel, P. Kiewe, M. Neumann, K. Jahnke, E. Thiel posted to pcnsl by eisei on 2009-01-06 10:03:25 as
	High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study [My Copy] Ann Oncol (26 October 2008), mdn628. by G. Illerhaus, R. Marks, F. Muller, et al.G. Ihorst, F. Feuerhake, M. Deckert, C. Ostertag, J. Finke posted to pcnsl by eisei on 2008-12-18 06:05:21 as
	Summary Statement on Primary Central Nervous System Lymphomas From the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002 [My Copy] J Clin Oncol, Vol. 21, No. 12. (15 June 2003), pp. 2407-2414. by Andres J. Ferreri, Lauren E. Abrey, Jean-Yves Blay, et al.Bettina Borisch, Jacob Hochman, Edward A. Neuwelt, Joachim Yahalom, Emanuele Zucca, Franco Cavalli, James Armitage, Tracy Batchelor posted to pcnsl by eisei on 2008-07-31 20:02:56 as
	Measurements of blood-brain barrier permeability in patients undergoing radiotherapy and chemotherapy for primary cerebral lymphoma. [My Copy] European journal of cancer (Oxford, England : 1990), Vol. 27, No. 11. (1991), pp. 1356-1361. by R. J. Ott, M. Brada, M. A. Flower, J. W. Babich, S. R. Cherry, B. J. Deehan posted to pcnsl by eisei on 2008-07-31 19:03:16 as
	Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national survey. [My Copy] Cancer, Vol. 110, No. 8. (15 October 2007), pp. 1803-1814. by I. S. Haldorsen, B. K. Krossnes, J. H. Aarseth, et al.D. Scheie, T. B. Johannesen, O. Mella, A. Espeland posted to pcnsl survey by eisei on 2008-07-11 08:58:48 as
	Incidence, clinical features, treatment and outcome of primary central nervous system lymphoma in Norway. [My Copy] Acta oncologica (Stockholm, Sweden), Vol. 43, No. 6. (2004), pp. 520-529. by I. Salvesen Haldorsen, J. H. Aarseth, A. Hollender, J. L. Larsen, A. Espeland, O. Mella posted to pcnsl by eisei on 2008-07-11 08:56:21 as
	A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy. [My Copy] Cancer, Vol. 89, No. 6. (15 September 2000), pp. 1359-1370. by G. M. Mead, N. M. Bleehen, A. Gregor, et al.J. Bullimore, D. Shirley, R. P. Rampling, J. Trevor, M. G. Glaser, P. Lantos, J. W. Ironside, T. H. Moss, M. Brada, J. B. Whaley, S. P. Stenning posted to pcnsl by eisei on 2008-06-25 11:27:19 as
	High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma. [My Copy] Bone marrow transplantation, Vol. 31, No. 8. (April 2003), pp. 679-685. by T. Cheng, P. Forsyth, A. Chaudhry, et al.D. Morris, S. Glück, J. A. Russell, D. A. Stewart posted to asct pcnsl pcnsl-apbsct by eisei on 2008-06-25 11:22:40 as
	High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 21, No. 24. (15 December 2003), pp. 4483-4488. by P. M. Poortmans, H. C. Kluin-Nelemans, H. Haaxma-Reiche, et al.M. Van't Veer, M. Hansen, P. Soubeyran, M. Taphoorn, J. Thomas, M. Van den Bent, M. Fickers, G. Van Imhoff, C. Rozewicz, I. Teodorovic, M. van Glabbeke, posted to pcnsl by eisei on 2008-06-25 11:00:52 as
	Primary central nervous system lymphoma in Japan 1995–1999: changes from the preceding 10 years [My Copy] Journal of Cancer Research and Clinical Oncology, Vol. 130, No. 6. (1 June 2004), pp. 351-356. by Yuta Shibamoto, Emiko Tsuchida, Kaori Seki, et al.Natsuo Oya, Masatoshi Hasegawa, Yukihiro Toda, Mitsuhiro Takemoto, Minako Sumi, Jun-Ichi Hiratsuka, Masahiko Oguchi, Masako Hosono, Shigeo Yasuda, Mitsuharu Sougawa, Yoshihisa Kakutoh, Naofumi Hayabuchi posted to pcnsl by eisei on 2008-06-25 10:56:12 as
	Combination Chemotherapy and Radiotherapy for Primary Central Nervous System Lymphoma: Radiation Therapy Oncology Group Study 93-10 [My Copy] J Clin Oncol, Vol. 20, No. 24. (15 December 2002), pp. 4643-4648. by Lisa M. Deangelis, Wendy Seiferheld, Clifford S. Schold, Barbara Fisher, Christopher J. Schultz posted to mpv pcnsl by eisei on 2008-06-25 10:46:41 as
	Cyclophosphamide, doxorubicin, vincristine, and prednisone for primary central nervous system lymphoma: Short-duration response and multifocal intracerebral recurrence preceding radiotherapy [My Copy] Neurology, Vol. 44, No. 9. (1 September 1994), 1721. by D. H. Lachance, D. M. Brizel, J. P. Gockerman, et al.E. C. Halperin, P. C. Burger, O. B. Boyko, M. T. Brown, S. C. Schold posted to chop pcnsl by eisei on 2008-06-25 10:33:43 as
	Primary non-Hodgkin's lymphoma of the CNS treated with BVAM or CHOD/BVAM chemotherapy before radiotherapy [My Copy] J Clin Oncol, Vol. 14, No. 3. (1 March 1996), pp. 945-954. by E. M. Bessell, F. Graus, J. A. Punt, et al.J. L. Firth, D. T. Hope, A. J. Moloney, A. Lopez-Guillermo, S. Villa posted to chop pcnsl by eisei on 2008-06-25 10:32:40 as
	Phase II Multicenter Study of Brief Single-Agent Methotrexate Followed by Irradiation in Primary CNS Lymphoma [My Copy] J Clin Oncol, Vol. 18, No. 3. (1 February 2000), 519. by P. Obrien, D. Roos, G. Pratt, et al.K. Liew, M. Barton, M. Poulsen, I. Olver, G. Trotter posted to pcnsl by eisei on 2008-06-25 10:24:19 as
	Primary central nervous system lymphoma [My Copy] Current Treatment Options in Neurology, Vol. 8, No. 4. (22 July 2006), pp. 346-357. by Hendrik Pels, Uwe Schlegel posted to pcnsl by eisei on 2008-06-23 09:58:14 as
	Intraventricular and Intravenous Treatment of a Patient with Refractory Primary CNS Lymphoma using Rituximab [My Copy] Journal of Neuro-Oncology, Vol. 59, No. 3. (2002), pp. 213-216. by H. Pels, H. Schulz, O. Manzke, E. Hom, A. Thall, A. Engert posted to pcnsl rituximab by eisei on 2008-06-23 08:45:45 as
	Primary CNS Lymphoma: Findings Outside the Brain [My Copy] Journal of Neuro-Oncology, Vol. 43, No. 3. (1 July 1999), pp. 227-230. by Ulrich Herrlinger posted to occult pcnsl by eisei on 2008-06-23 08:39:53 as
	The utility of body FDG PET in staging primary central nervous system lymphoma [My Copy] Neuro-oncol, Vol. 10, No. 2. (1 April 2008), pp. 223-228. by Nimish A. Mohile, Lisa M. Deangelis, Lauren E. Abrey posted to pcnsl by eisei on 2008-06-22 19:44:20 as
	Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma. [My Copy] Blood, Vol. 101, No. 3. (1 February 2003), pp. 815-821. by J. R. Smith, R. M. Braziel, S. Paoletti, M. Lipp, M. Uguccioni, J. T. Rosenbaum posted to chemokine pcnsl by eisei on 2008-06-21 12:49:22 as
	Malignant B cells from patients with primary central nervous system lymphoma express stromal cell-derived factor-1. [My Copy] American journal of clinical pathology, Vol. 127, No. 4. (April 2007), pp. 633-641. by J. R. Smith, K. M. Falkenhagen, S. E. Coupland, T. J. Chipps, J. T. Rosenbaum, R. M. Braziel posted to chemokine pcnsl by eisei on 2008-06-21 12:48:05 as
	Expression pattern and cellular sources of chemokines in primary central nervous system lymphoma [My Copy] Acta Neuropathologica, Vol. 114, No. 3. (September 2007), pp. 271-276. by Brunn, Anna, Montesinos-Rongen, et al. Manuel, Strack, Andreas, Reifenberger, Guido, Mawrin, Christian, Schaller, Carlo, Deckert, Martina posted to cxcr4 cxcr5 pcnsl by eisei on 2008-06-21 12:43:01 as
	Expression of the chemokine receptors CXCR4, CXCR5, and CCR7 in primary central nervous system lymphoma [My Copy] Blood, Vol. 106, No. 1. (1 July 2005), pp. 384-385. by Kristoph Jahnke, Sarah E. Coupland, Il-Kang Na, et al.Christoph Loddenkemper, Ulrich Keilholz, Agnieszka Korfel, Harald Stein, Eckhard Thiel, Carmen Scheibenbogen posted to ccr7 cxcr4 cxcr5 pcnsl by eisei on 2008-06-21 12:40:02 as
	Results of Treatment of 112 Cases of Primary CNS Lymphoma [My Copy] Jpn. J. Clin. Oncol., Vol. 38, No. 5. (1 May 2008), pp. 373-380. by Ryuya Yamanaka, Ken Morii, Yoshikatsu Shinbo, et al.Junpei Homma, Masakazu Sano, Naoto Tsuchiya, Naoki Yajima, Tetsuro Tamura, Hiroaki Hondoh, Hitoshi Takahashi, Tatsuyuki Kakuma, Ryuichi Tanaka posted to pcnsl by eisei on 2008-06-21 12:25:36 as
	Chemotherapy Delivery Issues in Central Nervous System Malignancy: A Reality Check [My Copy] J Clin Oncol, Vol. 25, No. 16. (1 June 2007), pp. 2295-2305. by Leslie L. Muldoon, Carole Soussain, Kristoph Jahnke, et al.Conrad Johanson, Tali Siegal, Quentin R. Smith, Walter A. Hall, Kullervo Hynynen, Peter D. Senter, David M. Peereboom, Edward A. Neuwelt posted to bbb pcnsl by eisei on 2008-06-21 12:06:25 as along with 1 person lrust
	Intraventricular and intravenous treatment of a patient with refractory primary CNS lymphoma using rituximab. [My Copy] Journal of neuro-oncology, Vol. 59, No. 3. (September 2002), pp. 213-216. by H. Pels, H. Schulz, O. Manzke, E. Hom, A. Thall, A. Engert posted to pcnsl rituximab by eisei on 2008-06-21 12:01:03 as
	Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide [My Copy] Neurology, Vol. 63, No. 5. (14 September 2004), pp. 901-903. by Roelien H. Enting, Alexis Demopoulos, Lisa M. Deangelis, Lauren E. Abrey posted to pcnsl rituximab temozolomide by eisei on 2008-06-20 20:20:16 as
	Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma [My Copy] Neurology, Vol. 69, No. 11. (11 September 2007), pp. 1178-1182. by Andreas F. Hottinger, Lisa M. Deangelis, Joachim Yahalom, Lauren E. Abrey posted to pcnsl by eisei on 2008-06-02 18:38:23 as
	Study of radiolabeled indium-111 and yttrium-90 ibritumomab tiuxetan in primary central nervous system lymphoma. [My Copy] Cancer, Vol. 110, No. 11. (1 December 2007), pp. 2528-2534. by F. M. Iwamoto, J. Schwartz, N. Pandit-Taskar, et al.S. Peak, C. R. Divgi, A. D. Zelenetz, J. Humm, L. E. Abrey posted to pcnsl by eisei on 2008-06-02 18:01:54 as
	Primary central nervous system lymphoma treated with high-dose methotrexate, high-dose busulfan/thiotepa, autologous stem-cell transplantation and response-adapted whole-brain radiotherapy: results of the multicenter Ostdeutsche Studiengruppe Hamato-Onkologie OSHO-53 phase II study [My Copy] Annals of Oncology, Vol. 18, No. 4. (1 April 2007), pp. 665-671. by Montemurro, M, Kiefer, et al. T, Schuler, F, Al-Ali, Hk, Wolf, H. H-, Herbst, R, Haas, A, Helke, K, Theilig, A, Lotze, C, Hirt, C, Niederwieser, D, Schwenke, M, For, posted to pcnsl pcnsl-apbsct by eisei on 2008-05-26 18:44:16 as
	Results of Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue in 22 Patients With Refractory or Recurrent Primary CNS Lymphoma or Intraocular Lymphoma [My Copy] J Clin Oncol, Vol. 19, No. 3. (1 February 2001), pp. 742-749. by Carole Soussain, Florence Suzan, Khe Hoang-Xuan, et al.Nathalie Cassoux, Vincent Levy, Nabih Azar, Coralie Belanger, Eddine Achour, Vincent Ribrag, Sophie Gerber, Jean-Yves Delattre, And V. Leblond posted to pcnsl pcnsl-apbsct by eisei on 2008-05-26 18:39:40 as
	Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: a pilot study [My Copy] J Neurol Neurosurg Psychiatry, Vol. 71, No. 1. (1 July 2001), pp. 118-122. by U. Schlegel, H. Pels, A. Glasmacher, et al.R. Kleinschmidt, I. Schmidt-Wolf, C. Helmstaedter, K. Fliessbach, M. Deckert, D. Van Roost, R. Fimmers, U. Bode, T. Klockgether posted to pcnsl by eisei on 2008-05-26 17:03:45 as
	Treatment of CNS lymphoma with the anti-CD20 antibody rituximab: experience with two cases and review of the literature. [My Copy] Onkologie, Vol. 26, No. 4. (August 2003), pp. 351-354. by H. Pels, H. Schulz, U. Schlegel, A. Engert posted to pcnsl rituximab by eisei on 2008-05-26 12:01:39 as
	German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma. [My Copy] Annals of neurology, Vol. 51, No. 2. (February 2002), pp. 247-252. by U. Herrlinger, M. Schabet, W. Brugger, et al.R. D. Kortmann, W. Küker, M. Deckert, C. Engel, H. J. Schmeck-Lindenau, H. G. Mergenthaler, P. Krauseneck, C. Benöhr, C. Meisner, O. D. Wiestler, J. Dichgans, L. Kanz, M. Bamberg, M. Weller posted to pcnsl by eisei on 2008-05-26 11:26:32 as
	High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group. [My Copy] Bone marrow transplantation, Vol. 38, No. 6. (September 2006), pp. 417-420. by P. Colombat, A. Lemevel, P. Bertrand, et al.V. Delwail, P. Rachieru, A. Brion, C. Berthou, J. O. Bay, R. Delepine, B. Desablens, S. Camilleri-Broët, C. Linassier, T. Lamy posted to pcnsl pcnsl-apbsct by eisei on 2008-05-26 10:06:13 as
	High-Dose Chemotherapy With Autologous Stem-Cell Transplantation and Hyperfractionated Radiotherapy As First-Line Treatment of Primary CNS Lymphoma [My Copy] J Clin Oncol, Vol. 24, No. 24. (20 August 2006), pp. 3865-3870. by Gerald Illerhaus, Reinhard Marks, Gabriele Ihorst, et al.Roland Guttenberger, Christoph Ostertag, Gunther Derigs, Norbert Frickhofen, Friedrich Feuerhake, Benedikt Volk, Jurgen Finke posted to pcnsl pcnsl-apbsct by eisei on 2008-05-26 09:55:51 as

Note: You may cite this page as: http://www.citeulike.org/user/eisei/tag/pcnsl

Result page: 1 2 Next

pcnsl	78
b-cell	74
antigen-processing	54
cd40-b	48
mhc-class-ii	34
tumor	33
cyclin-d1	31
treg	31
tumor-infiltrating	30
sarcoma	29
cyclin-a	27
epc	25
ctl	24
avidity	23
cd40l	22
lymphoma	22
tolerance	22
dc	21
eisei	21
cd40	20
cyclins	20
ccnd1	19
autophagy	18
breg	17
cancer	17
tumor-evasion	17
ebv	15
haplo	15
il-10	15
review	14
angiogenesis	13
til	13
aml	12
antigen-presentation	12
myeloma	12
cmv	11
pp65	11
rna	11
tlr	11
breast	10
cns	10
lipid-raft	10
rituximab	10
3d-videomicroscopy	9
b-cells	9
foxp3	9
immunotherapy	9
mtec	9
pcnsl-apbsct	9
pge2	9
regulatory	9
tumor-antigen	9
bcr	8
caebv	8
cd8	8
hypercvad	8
mice	8
proteasome	8
vaccine	8
central-torelance	7
colon	7
cross-presentation	7
amyloidosis	6
chloroquine	6
cpg	6
cyclin-a1	6
dendritic	6
elispot	6
gvhd	6
hdac	6
il-21	6
immunoediting	6
nela	6
tap	6
adoptive	5
allogenic	5
antigen	5
cd4	5
hiv	5
ido	5
mrna	5
selection	5
spheroid	5
transfection	5
transplantation	5
aplasticanemia	4
cancerstemcells	4
cd25	4
cd45ra	4
cea	4
chemokine	4
cnsrelapse	4
cyclin-b1	4
ferritin	4
htert	4
huvec	4
icp47	4
il-15	4
immunologicalsynapse	4
immunomonitoring	4
leukemia	4
mhc	4
mtx	4
phagocytosis	4
scd154	4
stem	4
t-cell	4
thymus	4
til-b	4
us6	4
aire	3
all	3
antigen-uptake	3
antiogenesis	3
apc	3
apoptosis	3
autoimmunity	3
cap1-6d	3
cd107	3
cd1d	3
chop	3
classification	3
cxcr4	3
cyclin	3
endothelial	3
fibromodulin	3
follicular	3
hla	3
hpv	3
hsp	3
il-12	3
lps	3
melanoma	3
memory	3
nk	3
npm1	3
rays	3
rist	3
tetramer	3
tolerogenicdc	3
vegf	3
alloreactive	2
b-all	2
bbb	2
brca1	2
ca2	2
cap1	2
cd200	2
cd200r	2
cd38	2
cll	2
ct-antigen	2
cxcr5	2
dna	2
dual-targeting	2
endocytosis	2
epitope	2
expression	2
fetal	2
fitc-dextran	2
flowcytometry	2
flt3	2
gene	2
heterocritic	2
hla-b	2
ig-transgenic	2
ihc	2
il-7r	2
imc	2
immortalization	2
inkt	2
intrathecal	2
itp	2
leak	2
mantle	2
mass-spectrometry	2
mds	2
microenviroment	2
microenvironment	2
migration	2
mthfr	2
mutation	2
naive	2
negative	2
neuroblastoma	2
nima	2
ova	2
pemphigoid	2
pet	2
platelet	2
promiscuous	2
ps-341	2
ptld	2
ra	2
rf-tricom	2
snp	2
splicing-variant	2
statin	2
synapse	2
t2	2
tgf-b	2
tgf-beta	2
tlr4	2
vaccination	2
wm	2
40-b	1
9r	1
ab-crystallin	1
abl	1
abvd	1
act1	1
acvbp	1
adeno	1
algorithm	1
anaergy	1
anergy	1
antibody	1
anticoaglant	1
antiplatelet	1
arg	1
asct	1
atra	1
baculovirus	1
bad	1
baff	1
bcl-2	1
brca2	1
brefeldin	1
burkitt	1
c4bp	1
cacner	1
cancer-antigen	1
cathepsin	1
ccr7	1
cd123	1
cd133	1
cd19	1
cd229	1
cd23	1
cd27	1
cd28	1
cd57	1
cd62l	1
cd70	1
cd80	1
cd83	1
cd86	1
cd9	1
cell-line	1
cells	1
cervical	1
cgvhd	1
cheson	1
cml	1
cp-870893	1
cryptic	1
ct	1
cystein	1
cytosolic	1
daclizumab	1
dec-205	1
dendritic-like	1
depocyt	1
dlbcl	1
dli	1
dqb1	1
ecfc	1
ecoli	1
eda	1
embryonic	1
endcytosis	1
er-phagosome	1
es	1
europeum	1
ewing	1
exercise	1
fas	1
fcgamma	1
fcl	1
fl	1
flamsa-ric	1
galectin-1	1
gallium	1
gemcitabine	1
genetherapy	1
gingival	1
glucarpidasemtx	1
gr-1	1
granzyme-b	1
h2o2	1
hd	1
hdmtx	1
hds	1
hematopoietic	1
her2	1
hla-a2	1
hla-do	1
hmb	1
hodgkin	1
hsc	1
hsct	1
hsp70	1
hsv-tk	1
hyperosmotic	1
hyporesponsiveness	1
idarubicin	1
ifn-g	1
igd	1
igg	1
il17	1
il-2	1
il21	1
il-4	1
il-7	1
in-situ-rtpcr	1
intestinal	1
intra-csf	1
isoform	1
kir	1
lag3	1
lamp1	1
l-asparaginase	1
lcl	1
leucinezipper	1
ligand	1
light	1
lpd	1
lung	1
lytic	1
macroenviroment	1
mage	1
meeting	1
mekk1	1
mha	1
mhc-ii	1
mhcpeptide-library	1
miha	1
mini-cd40l	1
monomer	1
mpn	1
mpv	1
mri	1
muc1	1
nabtt9607	1
nanotube	1
nausea	1
nci	1
nejm	1
nf-b	1
nf-kb	1
nsclc	1
nuclear	1
ny-eso-1	1
occult	1
ontak	1
op9	1
ovarian	1
p2x7	1
pbsct	1
pd-l1	1
peg	1
peptide	1
pha	1
phagosome	1
plasma	1
plasmacytoid	1
post-transplantation-cyclophosphamide	1
pr1	1
pr3	1
praffin	1
prame	1
prediction	1
presentation	1
ptd	1
qol	1
rapamycin	1
realtime-pcr	1
regulator	1
rejection	1
relapse	1
renal	1
rep	1
report	1
retroviral	1
rhabdomyosarcoma	1
riskfactor	1
rituxan	1
scd14	1
sec61	1
signaling	1
survey	1
survivin	1
syt-ssx	1
t-apc	1
targeting	1
taste-abnormality	1
tat	1
tc	1
tce	1
temozolomide	1
tetraspanin	1
tf-1	1
thp-1	1
thymocyte	1
tlr2	1
tlr9	1
tlt	1
tracking	1
transcriptional	1
transfer	1
transgenic	1
trimer	1
trypan-blue	1
u266	1
ul495	1
vaccinia	1
vascularization	1
vector	1
vip	1
vomiting	1
warfarin	1
web	1
who	1
wt1	1
wt-1	1
zavalin	1

eisei's pcnsl [78 articles] Export

eisei's tags